Stock AVRO TECTONIC THERAPEUTIC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Tectonic Therapeutic, Inc.

Equities

AVRO

US8789721086

Real-time Estimate Cboe BZX
Other stock markets
 15:28:57 2024-06-27 EDT 		5-day change 1st Jan Change
16.4 USD +2.92% Intraday chart for Tectonic Therapeutic, Inc. -6.51% -2.39%
06-20 Avrobio Closes Merger With Tectonic Therapeutic MT
06-20 Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Avrobio Closes Merger With Tectonic Therapeutic
MT
Tectonic Therapeutic, Inc. announced that it has received $96.599856 million in funding from Tas Partners, LLC
CI
AVROBIO, Inc.(NasdaqGS:AVRO) dropped from NASDAQ Composite Index
CI
Tectonic Therapeutic, Inc. completed the acquisition of AVROBIO, Inc. from a group of shareholders in a reverse merger transaction.
CI
Avrobio Insider Bought Shares Worth $971,493, According to a Recent SEC Filing
MT
AVROBIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
AVROBIO INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
BU
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure
AQ
North American Morning Briefing : Investors -2-
DJ
AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
BU
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic
PR
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders
BU
Transcript : AVROBIO, Inc., Tectonic Therapeutic, Inc. - M&A Call
AVROBIO and Tectonic Therapeutic Announce Merger
BU
Tectonic Therapeutic, Inc. announced that it expects to receive $96.599856 million in funding from Tas Partners, LLC
CI
AVROBIO, Inc. entered into an agreement to acquire Tectonic Therapeutic, Inc.
CI
North American Morning Briefing : S&P 500 Eyes -2-
DJ
Mizuho Securities Cuts Avrobio Price Target to $2 From $5, Buy Rating Kept
MT
North American Morning Briefing : Caution Dominates Ahead of CPI Print
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVRO Stock
  4. News Tectonic Therapeutic, Inc.